181 related articles for article (PubMed ID: 33873055)
1. The utility of Vibratip in accurate identification of loss of protective sensation in the contralateral foot of patients admitted with a diabetic foot ulcer.
Pasangha E; George B; Jayalakshmi V; Devi P; Ayyar V; Bantwal G
Diabetes Metab Syndr; 2021; 15(3):857-862. PubMed ID: 33873055
[TBL] [Abstract][Full Text] [Related]
2. The Performance and Interrater Agreement of Vibration Perception for the Diagnosis of Loss of Protective Sensation in People With Diabetes Mellitus.
Tentolouris A; Tentolouris N; Eleftheriadou I; Jude EB
Int J Low Extrem Wounds; 2023 Mar; 22(1):72-76. PubMed ID: 33624526
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes.
Bracewell N; Game F; Jeffcoate W; Scammell BE
Diabet Med; 2012 Dec; 29(12):1553-5. PubMed ID: 22672257
[TBL] [Abstract][Full Text] [Related]
4. Hidden dangers revealed by misdiagnosed diabetic neuropathy: A comparison of simple clinical tests for the screening of vibration perception threshold at primary care level.
Azzopardi K; Gatt A; Chockalingam N; Formosa C
Prim Care Diabetes; 2018 Apr; 12(2):111-115. PubMed ID: 29029862
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Clinical Tests for Peripheral Diabetic Neuropathy in a Type 1 Diabetes Cohort.
César Ernesto LC; Néstor MZ; Raúl IS; Francisco Javier PV; Tania S MU; Francisco BH; Alejandro CM; Marcela JZ; Almeda-Valdes P
Endocr Pract; 2021 Jun; 27(6):567-570. PubMed ID: 33798738
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test.
Oyer DS; Saxon D; Shah A
Endocr Pract; 2007; 13(1):5-10. PubMed ID: 17360294
[TBL] [Abstract][Full Text] [Related]
7. A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting.
Bowling FL; Abbott CA; Harris WE; Atanasov S; Malik RA; Boulton AJ
Diabet Med; 2012 Dec; 29(12):1550-2. PubMed ID: 22672290
[TBL] [Abstract][Full Text] [Related]
8. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
[TBL] [Abstract][Full Text] [Related]
9. Screening for the loss of protective sensation in people without a history of diabetic foot ulceration: Validation of two simple tests in India.
Chatzistergos PE; Kumar S; Sumathi CS; Mahadevan S; Vas P; Chockalingam N
Diabetes Res Clin Pract; 2023 Aug; 202():110810. PubMed ID: 37391033
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
Adams OP; Herbert JR; Howitt C; Unwin N
Diabet Med; 2019 Dec; 36(12):1629-1636. PubMed ID: 31094005
[TBL] [Abstract][Full Text] [Related]
11. Correlation between plantar foot temperature and diabetic neuropathy: a case study by using an infrared thermal imaging technique.
Bagavathiappan S; Philip J; Jayakumar T; Raj B; Rao PN; Varalakshmi M; Mohan V
J Diabetes Sci Technol; 2010 Nov; 4(6):1386-92. PubMed ID: 21129334
[TBL] [Abstract][Full Text] [Related]
12. Item reduction of the 39-item Rotterdam Diabetic Foot Study Test Battery using decision tree modelling.
Rinkel WD; van der Oest MJW; Coert JH
Diabetes Metab Res Rev; 2020 May; 36(4):e3291. PubMed ID: 31955486
[TBL] [Abstract][Full Text] [Related]
13. Which diabetic patients should receive podiatry care? An objective analysis.
McGill M; Molyneaux L; Yue DK
Intern Med J; 2005 Aug; 35(8):451-6. PubMed ID: 16176466
[TBL] [Abstract][Full Text] [Related]
14. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial.
Pham H; Armstrong DG; Harvey C; Harkless LB; Giurini JM; Veves A
Diabetes Care; 2000 May; 23(5):606-11. PubMed ID: 10834417
[TBL] [Abstract][Full Text] [Related]
15. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
[TBL] [Abstract][Full Text] [Related]
16. Mobile phone generated vibrations used to detect diabetic peripheral neuropathy.
May JD; Morris MWJ
Foot Ankle Surg; 2017 Dec; 23(4):281-284. PubMed ID: 29202988
[TBL] [Abstract][Full Text] [Related]
17. Relationship Between Glycated Hemoglobin and Vibration Perception Threshold in Diabetic Peripheral Neuropathy.
Maiya AG; Parameshwar A; Hande M; Nandalike V
Int J Low Extrem Wounds; 2020 Jun; 19(2):120-124. PubMed ID: 31838926
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
[TBL] [Abstract][Full Text] [Related]
19. [Examination of peripheral sensibility. Vibration test is more sensitive than monofilament test].
Sörman E; Edwall LL
Lakartidningen; 2002 Mar; 99(12):1339-40. PubMed ID: 11998167
[TBL] [Abstract][Full Text] [Related]
20. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
